SINOMED(SH:688108) Zheng Quan Zhi Xing·2025-09-04 16:06Group 1 - The company received an administrative regulatory decision from the Tianjin Securities Regulatory Bureau regarding the correction of accounting errors in its financial reports for the first three quarters of 2024, resulting in a reduction of investment income, operating profit, total profit, and net profit by 9.5882 million yuan [1][2] - The errors were primarily due to a miscalculation in the ownership percentage of eLum, a company acquired by the company, which led to the incorrect reporting of investment income [1][2] - The chairman and CFO of the company were found to have failed in their duties, leading to the decision to impose corrective measures on the company and regulatory talks with the individuals involved [2] Group 2 - The company is required to complete corrective actions within 30 days of receiving the decision and submit a written report to the Tianjin Securities Regulatory Bureau [2] - The company and its personnel are committed to learning from this incident, enhancing financial management and internal controls, and improving the quality of information disclosure to prevent future violations [3] - The administrative regulatory measures are not expected to impact the company's daily operations, and the company will continue to fulfill its information disclosure obligations in accordance with relevant regulations [3]